EuroEyes International Eye Clinic Limited (HKG:1846)
2.990
-0.020 (-0.66%)
Feb 12, 2026, 3:09 PM HKT
HKG:1846 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 724.44 | 715.68 | 714.29 | 610.29 | 632.93 | 473.82 | |
Revenue Growth (YoY) | -1.61% | 0.19% | 17.04% | -3.58% | 33.58% | 10.27% |
Cost of Revenue | 429.04 | 429.09 | 378.77 | 339.45 | 320.39 | 259.72 |
Gross Profit | 295.4 | 286.59 | 335.52 | 270.84 | 312.55 | 214.1 |
Selling, General & Admin | 201.95 | 196.48 | 162.22 | 134.01 | 122.75 | 106.54 |
Other Operating Expenses | -4.8 | -3.94 | -4.86 | -3.95 | -1.87 | -2.67 |
Operating Expenses | 197.46 | 192.88 | 157.58 | 130.1 | 120.99 | 103.89 |
Operating Income | 97.94 | 93.72 | 177.94 | 140.75 | 191.56 | 110.21 |
Interest Expense | -9.26 | -10.04 | -9.7 | -7.12 | -7.49 | -7 |
Interest & Investment Income | 19.75 | 23.57 | 19.33 | 1.14 | 0.14 | 2.52 |
Currency Exchange Gain (Loss) | -13.25 | 2.9 | -8.09 | 5.77 | 12.74 | -7.29 |
Other Non Operating Income (Expenses) | -6.01 | -5.75 | -4.44 | -3.62 | -0.97 | -0.64 |
EBT Excluding Unusual Items | 89.16 | 104.4 | 175.04 | 136.92 | 195.97 | 97.8 |
Merger & Restructuring Charges | - | - | - | -3.29 | - | - |
Gain (Loss) on Sale of Assets | 0.65 | -1.08 | -0.38 | 0.21 | -0.29 | 0.18 |
Other Unusual Items | 24.43 | 23.15 | 15.96 | -4.85 | - | 0.67 |
Pretax Income | 113.82 | 126.47 | 190.61 | 128.98 | 195.67 | 98.65 |
Income Tax Expense | 35.36 | 42.11 | 57.36 | 45.46 | 63.29 | 34.58 |
Earnings From Continuing Operations | 78.46 | 84.36 | 133.25 | 83.52 | 132.38 | 64.07 |
Minority Interest in Earnings | -1.92 | -2.07 | -2.01 | 5.95 | 1.18 | 1.51 |
Net Income | 76.53 | 82.29 | 131.24 | 89.47 | 133.56 | 65.58 |
Net Income to Common | 76.53 | 82.29 | 131.24 | 89.47 | 133.56 | 65.58 |
Net Income Growth | -29.08% | -37.30% | 46.69% | -33.01% | 103.66% | - |
Shares Outstanding (Basic) | 324 | 330 | 332 | 332 | 328 | 329 |
Shares Outstanding (Diluted) | 324 | 330 | 332 | 332 | 329 | 376 |
Shares Change (YoY) | -2.35% | -0.60% | -0.01% | 0.95% | -12.38% | 46.44% |
EPS (Basic) | 0.24 | 0.25 | 0.40 | 0.27 | 0.41 | 0.20 |
EPS (Diluted) | 0.24 | 0.25 | 0.40 | 0.27 | 0.41 | 0.17 |
EPS Growth | -27.38% | -36.93% | 46.70% | -33.64% | 132.43% | - |
Free Cash Flow | 131.44 | 117.41 | 102.94 | 152.74 | 229.28 | 40.12 |
Free Cash Flow Per Share | 0.41 | 0.36 | 0.31 | 0.46 | 0.70 | 0.11 |
Dividend Per Share | 0.061 | 0.065 | 0.100 | 0.063 | 0.099 | 0.030 |
Dividend Growth | -26.97% | -35.40% | 59.59% | -36.91% | 232.40% | - |
Gross Margin | 40.78% | 40.04% | 46.97% | 44.38% | 49.38% | 45.19% |
Operating Margin | 13.52% | 13.10% | 24.91% | 23.06% | 30.26% | 23.26% |
Profit Margin | 10.56% | 11.50% | 18.37% | 14.66% | 21.10% | 13.84% |
Free Cash Flow Margin | 18.14% | 16.41% | 14.41% | 25.03% | 36.23% | 8.47% |
EBITDA | 148.16 | 140.85 | 215.12 | 174.54 | 220.08 | 135.07 |
EBITDA Margin | 20.45% | 19.68% | 30.12% | 28.60% | 34.77% | 28.51% |
D&A For EBITDA | 50.22 | 47.13 | 37.18 | 33.79 | 28.52 | 24.87 |
EBIT | 97.94 | 93.72 | 177.94 | 140.75 | 191.56 | 110.21 |
EBIT Margin | 13.52% | 13.10% | 24.91% | 23.06% | 30.26% | 23.26% |
Effective Tax Rate | 31.07% | 33.30% | 30.09% | 35.25% | 32.34% | 35.05% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.